CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review-Reference-Cited by-同舟云学术

CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review

Published:2020 Issue: Volume:28 Page:102456
ISSN:2213-1582
Container-title:NeuroImage: Clinical
language:en
Short-container-title:NeuroImage: Clinical

Author:

Freeze Whitney M.^ORCID,van der Thiel Merel,de Bresser Jeroen,Klijn Catharina J.M.,van Etten Ellis S.,Jansen Jacobus F.A.,van der Weerd Louise,Jacobs Heidi I.L.,Backes Walter H.,van Veluw Susanne J.

Publisher

Elsevier BV

Subject

Cognitive Neuroscience,Clinical Neurology,Neurology,Radiology Nuclear Medicine and imaging

Reference69 articles.

1. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging;Starr;J. Neurol. Neurosurg. Psychiatry,2003

2. Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis;Cramer;Brain A J. Neurol.,2015

3. DCE-MRI blood-brain barrier assessment in acute ischemic stroke;Villringer;Neurology,2017

4. MRI measurements of blood-brain barrier function in dementia: a review of recent studies;Raja;Neuropharmacology,2018

5. Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations;Thrippleton;Alzheimer's & Dementia,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders;Neurobiology of Aging;2024-08

2. Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance;PLOS ONE;2024-05-29

3. Meningeal contrast enhancement in multiple sclerosis: assessment of field strength, acquisition delay, and clinical relevance;2024-03-07

4. Late/delayed gadolinium enhancement in MRI after intravenous administration of extracellular gadolinium-based contrast agents: is it worth waiting?;Magnetic Resonance Materials in Physics, Biology and Medicine;2024-02-22

5. A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-01